Thermo Fisher Scientific to Present at the Barclays Global Healthcare Conference on March 14, 2017

Tuesday, March 7, 2017 8:00 am EST

Dateline:

WALTHAM, Mass.

Public Company Information:

NYSE:
TMO

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Barclays Global Healthcare Conference on Tuesday, March 14, 2017, at 10:15 a.m. (EDT) at the Loews Miami Hotel, Miami, Fla.

You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Contact:

Thermo Fisher Scientific
Media Contact Information:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

Thermo Fisher Tweets

Introducing the first NGS-based IVD test for detection of genetic mutations in #NSCLC - Oncomine Dx Target Test… https://t.co/jR0BLLcoT0-3 hours 47 min ago
Hi, Can you plz share serial # of your Vanquish system & your location? We can connect you with the right team. Thanks.-7 hours 37 min ago
Scientists will do just about anything to get an automated cell counter! https://t.co/iWeiF2rvuX See the rebellion. https://t.co/8d3TauNecG-8 hours 9 min ago
What’s the advantage of exceptionally bright readouts for better discrimination of cell subpopulations?… https://t.co/0LbS3hM38m-8 hours 9 min ago
We've just received FDA approval for the first NGS-based IVD test for detection of genetic mutations in #NSCLC https://t.co/uXlmLlmTq1-1 day 1 hour ago